Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Q3 2023 Results Conference Call November 2, 2023 4:30 PM ET

Company Participants

Sharon Klahre - Head of Investor Relations

Michael Metzger - Chief Executive Officer

Neil Gallagher - President and Head of R&D

Keith Goldan - Chief Financial Officer

Peter Ordentlich - Chief Scientific Officer

Anjali Ganguli - Chief Business Officer

Conference Call Participants

Brad Canino - Stifel

Phil Nadeau - TD Cowen

Peter Lawson - Barclays

Michael Schmidt - Guggenheim

Kalpit Patel - B. Riley

Operator

Good day, everyone, and welcome to the Syndax Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.

At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.

Sharon Klahre

Thank you, Operator. Welcome, and thank you all for joining us today for a review of Syndax's third quarter 2023 financial and operating results. I'm Sharon Klahre, and with me this afternoon to provide an update on the Company's progress and discuss financial results are Michael Metzger, Chief Executive Officer; Dr. Neil Gallagher, President and Head of R&D; and Keith Goldan, Chief Financial Officer. Also joining us on the call today for the question-and-answer session are Dr. Peter Ordentlich, Chief Scientific Officer; and Dr. Anjali Ganguli, Chief Business Officer.

This call is accompanied by a slide deck that has been posted on the Investors page of the Company's website.

You can now turn to our forward-looking statements on Slide 2. Before we begin, I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these statements as a result of various important factors, including those discussed in the Risk Factors section in the Company's most recent Quarterly Report on Form 10-Q, as well as other reports filed with the SEC. Any forward-looking statements may represent our views as of today, November 2, 2023, only. A replay of this call will be available on the Company's website, www.syndax.com following its completion.

With that, I'm pleased to turn the call over to Michael Metzger, Chief Executive Officer, of Syndax.

Michael Metzger

Thank you, Sharon, and thank you all for joining the webcast. This continues to be an exciting year for Syndax and I look forward to sharing a number of updates with you on the significant progress we have made.